CLINICAL_TRIALS
trial_result
· 2026-06-08
Clinical Trial Update: MANDARIN (S6371) [Phase 3]
Summary
Phase 3 clinical trial update for MANDARIN (S6371) in inoperable hepatocellular carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Inoperable Hepatocellular Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING